Juskaran S Chadha, DO, MBA

Cancer Focus:
Bladder Cancer, Kidney (Renal Cell) Cancer, Lung Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

Dr. Chadha is an Assistant Professor at the University of South Florida, Morsani College of Medicine. After graduating from New York University, he received his medical degree from the New York Institute of Technology College of Osteopathic Medicine and completed an Internal Medicine Residency at Icahn School of Medicine at Mount Sinai. He completed his Hematology/Oncology Fellowship at the Donald and Barbara Zucker School of Medicine at Hofstra Northwell Health Lenox Hill Hospital. Most recently, Dr. Chadha received his MBA at the University of South Florida Muma College of Business.  Dr. Chadha’s clinical and research interests are in genitourinary tract tumors, including prostate cancer, bladder cancer, kidney cancer, testicular cancer, penile cancer, and thoracic malignancies. Administratively, Dr. Chadha serves as the Medical Director of Moffitt Cancer Center at Wesley Chapel and Medical Director of Infusion at this location. He is board certified in medical oncology, hematology, and internal medicine.

Education & Training

Fellowship:

• Donald and Barbara Zucker School of Medicine at Hofstra Northwell Health Cancer Institute - Hematology & Oncology

Residency:

• Icahn School of Medicine at Mount Sinai - Internal Medicine

Medical School:

• New York Institute of Technology - DO

Clinical Trial 21192
A Phase 2 Study of the Combination Dostarlimab with Niraparib In Patients with Penile Carcinoma Who Have Progressed Following Chemotherapy
Condition: Genitourinary
Intervention: Dostarlimab (); Niraparib (); TSR-042 (Dostarlimab)
Status: Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

• Zhao D, Khatri VM, Nakashima JY, Chadha J, Chatwal M, Zhang J, Ionescu F, Linscott JA, Li R, Poch M, Sexton W, Yu A, Spiess PE, Zemp L, Gilbert SM, Manley B, Yin V, Jain R, Torres-Roca J, Johnstone P, Yamoah K, Grass GD. Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality Therapy. J Urol. 2025 Nov.101097JU0000000000004849. Pubmedid: 41231842.
• Mustasam A, Parza K, Ionescu F, Gullapalli K, Paravathaneni M, Kim Y, Sandstrom RE, Al Assaad M, Grass GD, Johnstone P, Eschrich S, Safa H, Chadha J, Roman Souza G, David J, Semaan A, Zacharias NM, Pettaway C, Giuliano AR, Spiess PE, Chahoud J. The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis. J Natl Compr Canc Ne. 2025 Jan.23(2). Pubmedid: 39752880.
• Hatoum F, Souza GR, Johnson J, Miller J, Fazili A, Pettaway CA, Campbell MT, Neubauer R, Johns A, Mizelle SR, Kim Y, Chadha J, Zhang J, Jameel G, Oschmann E, Dhillon J, Moscu A, Janeway R, Harris W, Lu X, Spiess PE, Chahoud J. Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma. Future Oncol. 2025 Dec.21(28):3619-3627. Pubmedid: 41163621. Pmcid: PMC12674333.
• Zhang J, Chadha JS. Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies. Cancers (Basel). 2024 Sep.16(17). Pubmedid: 39272956. Pmcid: PMC11393880.
• Ionescu F, Nguyen J, Segura CM, Paravathaneni M, Grass GD, Johnstone P, Zacharias NM, Pettaway CA, Lu X, Kim Y, Whiting J, Dhillon J, Eschrich SA, Chadha J, Gullapalli K, Roman Souza G, Miyagi H, Manley BJ, Spiess PE, Chahoud J. Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage. Cancers (Basel). 2024 Jan.16(2). Pubmedid: 38275860. Pmcid: PMC10814242.
• Paravathaneni M, Safa H, Joshi V, Tamil MK, Adashek JJ, Ionescu F, Shah S, Chadha JS, Gilbert S, Manley B, Semaan A, Jim HSL, Kalos D, Kim Y, Spiess PE, Chahoud J. 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis. EClinicalMedicine. 2024 Feb.68:102413. Pubmedid: 38273886. Pmcid: PMC10809115.
• Chadha J, Chahoud J. Re: Bradley McGregor, Daniel M. Geynisman, Mauricio Burotto, et al. A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023;6:339-348. Eur Urol Oncol. 2024 Feb.7(1):172. Pubmedid: 37357090.
• Turner K, Kim DW, Gonzalez BD, Gore LR, Gurd E, Milano J, Riccardi D, Byrne M, Al-Jumayli M, de Castria TB, Laber DA, Hoffe S, Costello J, Robinson E, Chadha JS, Rajasekhara S, Hume E, Hagen R, Nguyen OT, Nardella N, Parker N, Carson TL, Tabriz AA, Hodul P. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial. Contemp Clin Trials Commun. 2024 Apr.38:101271. Pubmedid: 38440777. Pmcid: PMC10910065.
• Mason NT, Joshi VB, Adashek JJ, Kim Y, Shah SS, Schneider AM, Chadha J, Jim HSL, Byrne MM, Gilbert SM, Manley BJ, Spiess PE, Chahoud J. Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023 Jun.6(3):331-338. Pubmedid: 36797084.
• Parza K, Mustasam A, Ionescu F, Paravathaneni M, Sandstrom R, Safa H, Grass GD, Johnstone PA, Eschrich SA, Chadha J, Zacharias N, Pettaway CA, Spiess PE, Chahoud J. The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic Review. Cancers (Basel). 2023 Jul.15(14). Pubmedid: 37509374. Pmcid: PMC10378259.
• David J, Chumbalkar V, Chadha J. An insight into metastatic Leydig cell tumors: A case report. SAGE Open Med Case Rep. 2023 Jul.11. Pubmedid: 37434893. Pmcid: PMC10331185.
• Cui J, Tabbara S, Chadha J. The broad spectrum of tyrosine kinase inhibitors. Treatment of a rare EGFR R776H mutation with Osimertinib: Case report. SAGE Open Med Case Rep. 2023 Aug.11. Pubmedid: 37663150. Pmcid: PMC10469228.
• Chadha J, Chahoud J, Spiess PE. An update on treatment of penile cancer. Ther Adv Med Oncol. 2022 Sep.14. Pubmedid: 36172172. Pmcid: PMC9511530.
• Joshi VB, Chadha J, Chahoud J. Penile cancer: Updates in systemic therapy. Asian J Urol. 2022 Oct.9(4):374-388. Pubmedid: 36381603. Pmcid: PMC9643277.
• Chadha J, Adashek JJ, Jim H, Kim Y, Semaan A, Chakiryan NH, Safa H, Hajiran A, Sexton W, Gilbert SM, Manley BJ, Spiess PE, Chahoud J. Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Miss. Clin Genitourin Cancer. 2022 Apr.20(2):e158-e165. Pubmedid: 34974985.
• Zhong L, Chadha J, Ameri A. A Curious Case of Pseudothrombocytopenia due to In Vitro Agglutination. Case Rep Hematol. 2020 Feb.2020:6236350. Pubmedid: 32099698. Pmcid: PMC7040393.
• Chadha J, Sahai T, Schwimmer J, Shani D. A 30-Year-Old Carrier of Gaucher Disease with Multiple Myeloma. Case Rep Oncol Med. 2019 Feb.2019:6469196. Pubmedid: 30906609. Pmcid: PMC6393880.
• Chadha J, Hussein S, Zhan Y, Shulman J, Brody J, Ratner L, Steinberg A. Liposomal Vincristine as a Bridge Therapy Prior to CAR-T Therapy in Relapsed and Refractory Diffuse Large B-Cell Lymphoma?. Int J Hematol Oncol Stem Cell Res. 2019 Apr.13(2):102-107. Pubmedid: 31372204. Pmcid: PMC6660481.
• Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney BE, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck. Oral Oncol. 2017 Jul.70:14-22. Pubmedid: 28622886.
• Chadha J, Teng MS, Teruya-Feldstein J, Bakst RL. Radiation for MALT of the Submandibular Gland. Case Rep Hematol. 2017 Feb.2017:8397621. Pubmedid: 28163943. Pmcid: PMC5253503.
• Hu KS, Mourad WF, Gamez M, Safdieh J, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney B, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017 Aug.39(8):1647-1654. Pubmedid: 28474380.